NR3C2 and renal fibrosis: In diabetic mice fed a high-salt diet, the novel nonsteroidal MRA esaxerenone demonstrated efficacy in inhibiting renal inflammation and renal fibrosis by selectively blocking MR, as evidenced by its superior efficacy compared to spironolactone [60].